The coronavirus disease (COVID-19) spread rapidly around the world. Two types of approaches have been applied to use of face masks as a tool to prevent the spread this disease in society. The aim of the systematic review was to assess the effectiveness of face masks against the novel coronavirus. A literature search was performed using different databases until April 30, 2020. Search terms were `facemasks', `novel coronavirus', and `healthcare workers'. Five studies were included in the systematic review. A study stated that no difference between surgical and cotton masks. Also, two studies have emphasized the use of surgical masks or N95 respirators by medical staff, and two other studies emphasized the use of any type of face mask by general public. More studies in controlled contexts and studies of infections in healthcare and community places are needed for better definition of the effectiveness of face masks in preventing coronavirus.
1 January 2024 in Journal of Education and Health Promotion
BACKGROUND: Clinical symptoms and treatment adherence are one of the most important problems in dialysis patients. Psychological treatments can be effective in reducing the problems of these patients. Therefore, this study aimed at investigating the effectiveness of acceptance and commitment therapy (ACT) on clinical symptoms and treatment adherence in these patients. MATERIALS AND METHOD: This study was a quasi-experimental study with the experimental and control groups in the dialysis clinic of Torbat-e Heydarieh City in 2012. The sample consisted of 40 people who were referred to the dialysis clinic, and the available sampling method was used to randomly assign participants to the experimental and control groups. In the experimental group, ACT was performed in eight sessions of 90 minutes. Questionnaires of Depression, Anxiety, and Stress Scale (DASS-21) and general adherence scale were used. Data were analyzed using Statistical Package for the Social Sciences (SPSS 21) software and multivariate analysis of covariance (MANCOVA) test. RESULTS: There was a significant difference between the mean scores of clinical symptoms and treatment adherence variables in the experimental and control groups (P < 0.05). The effect of this treatment on reducing the clinical symptoms score was 48%, and on increasing the treatment, the adherence score was 44%. CONCLUSION: ACT can reduce clinical symptoms and increase treatment adherence in dialysis patients, so it is suggested to use this intervention in the design of treatment plans for dialysis patients.
25 August 2022 in Journal of Education and Health Promotion
BACKGROUND: One of the important causes of anxiety in COVID-19 disease is the inability to regulate emotion and lack of self-control during threatening conditions. The psychotherapy technique has been effective in reducing these symptoms. Therefore, this study attempted to evaluate the effectiveness of compassion-based therapy on emotion regulation and self-control in patients with COVID-19 after discharge. MATERIALS AND METHOD: It was a quasi-experimental pretest-posttest study with a control group. The statistical population consisted of 30 men (15 in each group) who were in the quarantine period of COVID-19 disease. Available sampling was used and the participants were randomly assigned to experimental and control groups. In the experimental group, compassion-based treatment was performed in 10 sessions of 90 min. Tanji's self-control questionnaire and Garnofsky's Emotion Regulation questionnaires were used. Data analysis were performed using SPSS 21 software and multivariate analysis of covariance. RESULTS: There was a significant difference between the mean scores of emotion regulation and self-control variables in the experimental and control groups ( P < 0.001). The effect of this treatment on increasing the emotion regulation score was 49% and on increasing the self-control score was 37%. CONCLUSION: Compassion-based therapy can increase cognitive regulation and improve self-control in patients with COVID-19 disease. It is suggested that this intervention can be used in psychological treatment programs.
25 September 2017 in Bioscience Biotechnology Research Communications
The COVID-19 pandemic significantly impacted global mental health. Iran, with its high infection rates and prolonged restrictions, faced a notable increase in mental health issues. This study aimed to evaluate the prevalence of mental disorders during and after the COVID-19 pandemic among residents of eastern Iran and identify associated factors. A descriptive cross-sectional study was conducted on 800 residents of Torbat Heydariyeh using random sampling. Data were collected through home interviews between June 2020 and June 2023. Mental health was assessed using the General Health Questionnaire-28 (GHQ-28), with demographic data collected through a structured form. Statistical analyses included independent t-tests, ANOVA, chi-square tests, and logistic regression, with a significance threshold of p ≤ 0.05. The prevalence of mental disorders was significantly higher during the pandemic (40.0%) compared to the post COVID-19 period (27.5%) (p < 0.001). Gender, economic status, and medical history were major determinants of mental health during the pandemic. Women (AOR = 1.92, 95% CI = 1.37–2.68), individuals with poor economic status (AOR = 2.34, 95% CI = 1.46–3.76), and those with a history of illness (AOR = 1.88, 95% CI = 1.21–2.92) had significantly higher odds of experiencing mental disorders. post COVID-19 period, economic status remained the only significant factor (AOR = 1.79, 95% CI = 1.22–2.63). This study highlights significant and enduring psychological impacts of the COVID-19 pandemic, particularly among socioeconomically disadvantaged groups. Interventions focusing on economic support and targeted mental health strategies are critical to mitigating long-term effects.
Introduction: COVID-19 pandemic has a significant impact on mental health including anxiety and depression and can weaken the immune system and make a person more vulnerable to the disease. Psychotherapy techniques have been effective in reducing these disorders. Therefore, this study aimed to investigate the effect of dialectical behavior therapy on depression and anxiety in patients discharged from COVID-19.Methods: It was a randomized controlled trial (RCT). The statistical population consisted of 30 men who underwent COVID -19 disease quarantine. Convenience sampling was used and the patients were randomly assigned to experimental and control groups. In the experimental group, dialectical behavior therapy was performed in 10 sessions of 90 minutes. The Beck Depression Inventory (BDI) and the Beck Anxiety Inventory (BAI) were used. Data were analyzed using SPSS 21 software and multivariate analysis of variance.Results: There was a significant difference between the mean scores of depression and anxiety in the experimental and control groups (p<0.001). The effect of this treatment on reducing the score of depression was 68% and on reducing the score of anxiety was 54%.Conclusion: Dialectical behavior therapy can reduce anxiety and depression in patients with COVID-19 disease. It is suggested that this intervention can be used in psychological treatment programs.